CGCMEDIUM SIGNALFINANCIAL10-K

Canopy Growth Corporation shows meaningful operational improvement with substantially reduced losses and liabilities, though cash position weakened and the company maintains early-stage development risks.

The company demonstrated notable progress in cost management with operating losses improving substantially alongside reduced SG&A expenses and interest costs, suggesting management's restructuring efforts are taking effect. However, the decline in cash reserves and continued negative operating cash flow indicate ongoing liquidity challenges that require monitoring, particularly given the company's acknowledgment that it remains in early development stages within a new industry.

Comparing 2025-05-30 vs 2024-05-30View on EDGAR →
FINANCIAL ANALYSIS

CGC's balance sheet contracted significantly with total assets declining 29.4% to $917.7M, driven primarily by substantial reductions in both current liabilities (down 59.8%) and total liabilities (down 46.2%), suggesting major debt restructuring or settlement activities. Operating performance improved meaningfully with operating losses narrowing substantially while SG&A expenses declined 26.1% and interest expense fell 29.2%. The company's cash position weakened to $113.8M from $170.3M, and operating cash flow remained negative at -$165.8M, though this represents improvement from the prior year's -$281.9M outflow.

FINANCIAL STATEMENT CHANGES
Current Liabilities
Balance Sheet
-59.8%
$234.7M$94.4M

Current liabilities reduced — improved short-term financial position and working capital health.

Operating Income
P&L
+48.8%
-$228.7M-$117.1M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Total Liabilities
Balance Sheet
-46.2%
$799.8M$430.5M

Liabilities reduced 46.2% — deleveraging improves balance sheet strength and financial flexibility.

Operating Cash Flow
Cash Flow
+41.2%
-$281.9M-$165.8M

Operating cash flow surged 41.2% — exceptional cash generation, highest quality earnings signal.

R&D Expense
P&L
-40.5%
$4.6M$2.7M

R&D spending cut 40.5% — could signal cost discipline or concerning reduction in innovation investment.

Cash & Equivalents
Balance Sheet
-33.2%
$170.3M$113.8M

Cash declined 33.2% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Assets
Balance Sheet
-29.4%
$1.3B$917.7M

Total assets contracted 29.4% — asset sales, write-downs, or balance sheet optimization underway.

Interest Expense
P&L
-29.2%
$105.4M$74.6M

Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.

SG&A Expense
P&L
-26.1%
$229.4M$169.6M

SG&A reduced 26.1% — improved cost efficiency or headcount reduction improving operating margins.

Inventory
Balance Sheet
+24.7%
$77.3M$96.4M

Inventory built 24.7% — monitor whether demand supports this build or if write-downs may follow.

LANGUAGE CHANGES
NEW — 2025-05-30
PRIOR — 2024-05-30
ADDED
All references to dollars or C$ are to Canadian dollars and all references to US$ are to U.S.
We are in the early stages of developing global infrastructure in a new industry and therefore we are subject to many risks common in developing companies.
The anticipated benefits of the strategy involving Canopy USA may not be realized and the fair value of our equity method investment in Canopy USA is volatile.
In the event Acreage cannot satisfy its debt obligations as they become due, the Acquired Debt (as defined below) may not be repaid and the Company may lose the entirety of its investment.
The price of the Canopy Shares has been and may continue to be highly volatile.
We are a collective of dynamic and engaged leaders, united by a passion for cannabis, focused on delighting our consumers and medical cannabis patients while creating value for our stakeholders and one another.
This is why we incorporate robust and stringent product safety measures and responsible-use education initiatives designed to create and sustain better places to live and work together.
Engaged Leadership: We depend on the shared purpose, passion and leadership of world-class talent.
We strive to live and lead by example by creating equity in our talent processes and encouraging an inclusive environment for all.
We are driven by an unwavering commitment to providing our consumers with the best possible experiences rooted in our vision of unleashing the power of cannabis to improve lives.
REMOVED
All references to dollars or CDN$ are to Canadian dollars and all references to US$ are to U.S.
federal law to permit the general cultivation, distribution, and possession of marijuana, or to remove the regulation of such activities from the federal laws of the United States (the Triggering Event ), and the satisfaction or waiver of the conditions to closing the acquisition of Acreage Holdings, Inc.
We have a limited operating history and our growth strategy may not be successful.
The anticipated benefits of the strategy involving Canopy USA may not be realized.
The price of our common shares has been and may continue to be highly volatile.
Our approach is grounded in our responsibility to operate with integrity, intention, and values, while consistently seeking opportunities to meet the needs of our consumers with premium branded products.
That is why we incorporate robust and stringent product safety efforts and responsible-use education initiatives designed to create and sustain better places to live and work together.
We want to leverage our leadership role in the cannabis industry to undo the harms for those affected by the historic criminalization of cannabis, including communities of color that have been disproportionately impacted.
We strive to live and lead by example by creating equity in our talent processes and encouraging an inclusive environment for all traditionally underrepresented groups.
Employee Values: We depend on the shared purpose, passion and leadership of world-class talent.
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →